Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Cell Biol. 2024 May;26(5):825-838. doi: 10.1038/s41556-024-01402-1. Epub 2024 Apr 11.
Blocking the import of nutrients essential for cancer cell proliferation represents a therapeutic opportunity, but it is unclear which transporters to target. Here we report a CRISPR interference/activation screening platform to systematically interrogate the contribution of nutrient transporters to support cancer cell proliferation in environments ranging from standard culture media to tumours. We applied this platform to identify the transporters of amino acids in leukaemia cells and found that amino acid transport involves high bidirectional flux dependent on the microenvironment composition. While investigating the role of transporters in cystine starved cells, we uncovered a role for serotonin uptake in preventing ferroptosis. Finally, we identified transporters essential for cell proliferation in subcutaneous tumours and found that levels of glucose and amino acids can restrain proliferation in that environment. This study establishes a framework for systematically identifying critical cellular nutrient transporters, characterizing their function and exploring how the tumour microenvironment impacts cancer metabolism.
阻断对癌细胞增殖至关重要的营养物质的进口代表了一种治疗机会,但尚不清楚应针对哪些转运蛋白。在这里,我们报告了一个 CRISPR 干扰/激活筛选平台,用于系统研究营养转运蛋白对支持从标准培养基到肿瘤等各种环境中癌细胞增殖的贡献。我们将该平台应用于鉴定白血病细胞中氨基酸的转运蛋白,发现氨基酸的转运涉及到依赖于微环境组成的双向高流量。在研究转运蛋白在胱氨酸饥饿细胞中的作用时,我们发现 5-羟色胺摄取在防止铁死亡中起作用。最后,我们确定了在皮下肿瘤中增殖所必需的转运蛋白,并发现葡萄糖和氨基酸的水平可以抑制该环境中的增殖。这项研究为系统地鉴定关键的细胞营养转运蛋白、表征其功能以及探索肿瘤微环境如何影响癌症代谢奠定了框架。
Pharmacol Ther. 2009-1
Curr Opin Plant Biol. 2012-2-25
Mol Aspects Med. 2015-12-23
Int J Mol Sci. 2020-12-22
Trends Endocrinol Metab. 2022-2
Cell Death Discov. 2025-7-16
J Clin Invest. 2025-7-15
Pharmaceutics. 2025-5-23
Mol Syst Biol. 2025-5-12
Mol Syst Biol. 2025-5-12
Nat Metab. 2025-4-28
Nat Rev Cancer. 2022-7
Cancer Discov. 2022-1